US Stock MarketDetailed Quotes

RUBY Rubius Therapeutics

Watchlist
  • 0.057000
  • 0.0000000.00%
15min DelayClose Dec 29 16:00 ET
5.16MMarket Cap-28P/E (TTM)

Rubius Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-34.62%127.25M
-96.37%1.95M
-37.00%31.53M
-14.06%42.91M
24.31%50.86M
16.92%194.62M
35.28%53.73M
24.55%50.05M
32.43%49.92M
-16.24%40.92M
Selling and administrative expenses
-41.85%30.84M
-92.35%1.06M
-39.34%7.3M
-28.47%9.91M
-5.11%12.56M
5.34%53.03M
-1.40%13.9M
0.49%12.04M
19.39%13.85M
4.55%13.24M
-General and administrative expense
-41.85%30.84M
-92.35%1.06M
-39.34%7.3M
-28.47%9.91M
-5.11%12.56M
5.34%53.03M
-1.40%13.9M
0.49%12.04M
19.39%13.85M
4.55%13.24M
Research and development costs
-31.90%96.41M
-97.77%888K
-36.26%24.23M
-8.52%33M
38.38%38.3M
21.95%141.59M
55.47%39.82M
34.76%38.01M
38.23%36.07M
-23.51%27.68M
Operating profit
34.62%-127.25M
96.37%-1.95M
37.00%-31.53M
14.06%-42.91M
-24.31%-50.86M
-16.92%-194.62M
-35.28%-53.73M
-24.55%-50.05M
-32.43%-49.92M
16.24%-40.92M
Net non-operating interest income expense
52.01%-3.04M
176.26%1.26M
20.38%-1.34M
-6.92%-1.38M
8.19%-1.58M
-161.57%-6.34M
-47.05%-1.65M
-77.50%-1.69M
-207.66%-1.29M
-2,790.63%-1.72M
Non-operating interest income
800.00%819K
675.00%124K
1,604.35%392K
880.77%255K
84.62%48K
-94.83%91K
-79.49%16K
-89.69%23K
-93.66%26K
-97.52%26K
Non-operating interest expense
-39.96%3.86M
-168.07%-1.13M
1.46%1.74M
24.24%1.63M
-6.81%1.63M
53.74%6.43M
38.81%1.66M
45.74%1.71M
58.45%1.31M
77.46%1.75M
Other net income (expense)
-1,219.06%-49.37M
-5,608.50%-19.45M
-1,202.50%-30M
-96.11%40K
-89.97%31K
286.34%4.41M
18.86%353K
858.10%2.72M
294.25%1.03M
3.00%309K
Special income (charges)
---51.2M
---21.15M
---30.05M
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
--51.2M
--21.15M
--30.05M
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-58.66%1.82M
381.59%1.7M
-98.05%53K
-96.11%40K
-89.97%31K
286.34%4.41M
18.86%353K
858.10%2.72M
294.25%1.03M
3.00%309K
Income before tax
8.59%-179.67M
63.40%-20.14M
-28.27%-62.87M
11.84%-44.24M
-23.82%-52.41M
-17.18%-196.55M
-35.72%-55.02M
-19.98%-49.02M
-32.56%-50.18M
12.70%-42.33M
Income tax
Net income
8.59%-179.67M
63.40%-20.14M
-28.27%-62.87M
11.84%-44.24M
-23.82%-52.41M
-17.18%-196.55M
-35.72%-55.02M
-19.98%-49.02M
-32.56%-50.18M
12.70%-42.33M
Net income continuous Operations
8.59%-179.67M
63.40%-20.14M
-28.27%-62.87M
11.84%-44.24M
-23.82%-52.41M
-17.18%-196.55M
-35.72%-55.02M
-19.98%-49.02M
-32.56%-50.18M
12.70%-42.33M
Minority interest income
Net income attributable to the parent company
8.59%-179.67M
63.40%-20.14M
-28.27%-62.87M
11.84%-44.24M
-23.82%-52.41M
-17.18%-196.55M
-35.72%-55.02M
-19.98%-49.02M
-32.56%-50.18M
12.70%-42.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.59%-179.67M
63.40%-20.14M
-28.27%-62.87M
11.84%-44.24M
-23.82%-52.41M
-17.18%-196.55M
-35.72%-55.02M
-19.98%-49.02M
-32.56%-50.18M
12.70%-42.33M
Basic earnings per share
10.76%-1.99
63.93%-0.22
-27.27%-0.7
12.50%-0.49
-13.73%-0.58
-7.21%-2.23
-22.00%-0.61
-7.84%-0.55
-19.15%-0.56
15.00%-0.51
Diluted earnings per share
10.76%-1.99
63.93%-0.22
-27.27%-0.7
12.50%-0.49
-13.73%-0.58
-7.21%-2.23
-22.00%-0.61
-7.84%-0.55
-19.15%-0.56
15.00%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -34.62%127.25M-96.37%1.95M-37.00%31.53M-14.06%42.91M24.31%50.86M16.92%194.62M35.28%53.73M24.55%50.05M32.43%49.92M-16.24%40.92M
Selling and administrative expenses -41.85%30.84M-92.35%1.06M-39.34%7.3M-28.47%9.91M-5.11%12.56M5.34%53.03M-1.40%13.9M0.49%12.04M19.39%13.85M4.55%13.24M
-General and administrative expense -41.85%30.84M-92.35%1.06M-39.34%7.3M-28.47%9.91M-5.11%12.56M5.34%53.03M-1.40%13.9M0.49%12.04M19.39%13.85M4.55%13.24M
Research and development costs -31.90%96.41M-97.77%888K-36.26%24.23M-8.52%33M38.38%38.3M21.95%141.59M55.47%39.82M34.76%38.01M38.23%36.07M-23.51%27.68M
Operating profit 34.62%-127.25M96.37%-1.95M37.00%-31.53M14.06%-42.91M-24.31%-50.86M-16.92%-194.62M-35.28%-53.73M-24.55%-50.05M-32.43%-49.92M16.24%-40.92M
Net non-operating interest income expense 52.01%-3.04M176.26%1.26M20.38%-1.34M-6.92%-1.38M8.19%-1.58M-161.57%-6.34M-47.05%-1.65M-77.50%-1.69M-207.66%-1.29M-2,790.63%-1.72M
Non-operating interest income 800.00%819K675.00%124K1,604.35%392K880.77%255K84.62%48K-94.83%91K-79.49%16K-89.69%23K-93.66%26K-97.52%26K
Non-operating interest expense -39.96%3.86M-168.07%-1.13M1.46%1.74M24.24%1.63M-6.81%1.63M53.74%6.43M38.81%1.66M45.74%1.71M58.45%1.31M77.46%1.75M
Other net income (expense) -1,219.06%-49.37M-5,608.50%-19.45M-1,202.50%-30M-96.11%40K-89.97%31K286.34%4.41M18.86%353K858.10%2.72M294.25%1.03M3.00%309K
Special income (charges) ---51.2M---21.15M---30.05M----------0--0--0--------
-Less：Restructuring and merger&acquisition --51.2M--21.15M--30.05M----------0--0--0--------
Other non- operating income (expenses) -58.66%1.82M381.59%1.7M-98.05%53K-96.11%40K-89.97%31K286.34%4.41M18.86%353K858.10%2.72M294.25%1.03M3.00%309K
Income before tax 8.59%-179.67M63.40%-20.14M-28.27%-62.87M11.84%-44.24M-23.82%-52.41M-17.18%-196.55M-35.72%-55.02M-19.98%-49.02M-32.56%-50.18M12.70%-42.33M
Income tax
Net income 8.59%-179.67M63.40%-20.14M-28.27%-62.87M11.84%-44.24M-23.82%-52.41M-17.18%-196.55M-35.72%-55.02M-19.98%-49.02M-32.56%-50.18M12.70%-42.33M
Net income continuous Operations 8.59%-179.67M63.40%-20.14M-28.27%-62.87M11.84%-44.24M-23.82%-52.41M-17.18%-196.55M-35.72%-55.02M-19.98%-49.02M-32.56%-50.18M12.70%-42.33M
Minority interest income
Net income attributable to the parent company 8.59%-179.67M63.40%-20.14M-28.27%-62.87M11.84%-44.24M-23.82%-52.41M-17.18%-196.55M-35.72%-55.02M-19.98%-49.02M-32.56%-50.18M12.70%-42.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.59%-179.67M63.40%-20.14M-28.27%-62.87M11.84%-44.24M-23.82%-52.41M-17.18%-196.55M-35.72%-55.02M-19.98%-49.02M-32.56%-50.18M12.70%-42.33M
Basic earnings per share 10.76%-1.9963.93%-0.22-27.27%-0.712.50%-0.49-13.73%-0.58-7.21%-2.23-22.00%-0.61-7.84%-0.55-19.15%-0.5615.00%-0.51
Diluted earnings per share 10.76%-1.9963.93%-0.22-27.27%-0.712.50%-0.49-13.73%-0.58-7.21%-2.23-22.00%-0.61-7.84%-0.55-19.15%-0.5615.00%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data